Literature DB >> 8869293

Role of macrophages in acetaminophen (paracetamol)-induced hepatotoxicity.

R D Goldin1, I D Ratnayaka, C S Breach, I N Brown, S N Wickramasinghe.   

Abstract

Research into the pathogenesis of acetaminophen (paracetamol)-induced hepatotoxicity has concentrated on the generation of toxic metabolites by the hepatocytes. It has, however, recently been shown that human macrophages cultured with acetaminophen secrete increased quantities of tumour necrosis factor (TNF). This study examines whether macrophages have a direct role in acetaminophen toxicity, using a mouse model in which it is possible to eliminate more that 99 per cent of hepatic macrophages by previously injecting liposomes containing dichloromethylene disphosphonate (DMDP). Acetaminophen-induced liver damage was assessed biochemically and histologically. It was shown that the liver damage occurring 0.5, 1, and 2 h after an intraperitoneal injection of acetaminophen was significantly less in mice previously injected with liposomes containing DMDP than in previously untreated mice, or mice previously injected with empty liposomes. By 4 h there was no difference between the groups. We conclude that macrophages play an early and probably a direct role in mediating the liver damage due to acetaminophen. This is consistent with the role that macrophages have been shown to play in the pathogenesis of alcohol-induced liver damage.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8869293     DOI: 10.1002/(SICI)1096-9896(199608)179:4<432::AID-PATH609>3.0.CO;2-S

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  20 in total

Review 1.  The functions of cytokines and their uses in toxicology.

Authors:  J R Foster
Journal:  Int J Exp Pathol       Date:  2001-06       Impact factor: 1.925

2.  NMR-based metabolomics of mammalian cell and tissue cultures.

Authors:  Nelly Aranibar; Michael Borys; Nancy A Mackin; Van Ly; Nicholas Abu-Absi; Susan Abu-Absi; Matthias Niemitz; Bernhard Schilling; Zheng Jian Li; Barry Brock; Reb J Russell; Adrienne Tymiak; Michael D Reily
Journal:  J Biomol NMR       Date:  2011-03-04       Impact factor: 2.835

3.  Increased serum enzyme levels associated with kupffer cell reduction with no signs of hepatic or skeletal muscle injury.

Authors:  Zaher A Radi; Petra H Koza-Taylor; Rosonald R Bell; Leslie A Obert; Herbert A Runnels; Jean S Beebe; Michael P Lawton; Seth Sadis
Journal:  Am J Pathol       Date:  2011-05-13       Impact factor: 4.307

Review 4.  Acetaminophen hepatotoxicity: An update.

Authors:  C J McClain; S Price; S Barve; R Devalarja; S Shedlofsky
Journal:  Curr Gastroenterol Rep       Date:  1999 Feb-Mar

Review 5.  Macrophages and tissue injury: agents of defense or destruction?

Authors:  Debra L Laskin; Vasanthi R Sunil; Carol R Gardner; Jeffrey D Laskin
Journal:  Annu Rev Pharmacol Toxicol       Date:  2011       Impact factor: 13.820

6.  A central role for CD68(+) macrophages in hepatopulmonary syndrome. Reversal by macrophage depletion.

Authors:  Thenappan Thenappan; Ankush Goel; Glenn Marsboom; Yong-Hu Fang; Peter T Toth; Hannah J Zhang; Hidemi Kajimoto; Zhigang Hong; Jonathan Paul; Christian Wietholt; Jennifer Pogoriler; Lin Piao; Jalees Rehman; Stephen L Archer
Journal:  Am J Respir Crit Care Med       Date:  2010-12-10       Impact factor: 21.405

Review 7.  Kupffer cells in non-alcoholic fatty liver disease: the emerging view.

Authors:  György Baffy
Journal:  J Hepatol       Date:  2009-03-31       Impact factor: 25.083

8.  Phagocytosis of Treponema pallidum and reactive oxygen species production by isolated rat Kupffer cells.

Authors:  Antonella Marangoni; Rita Aldini; Massimo Guardigli; Vittorio Sambri; Lorenzo Giacani; Marco Montagnani; Aldo Roda; Roberto Cevenini
Journal:  Med Microbiol Immunol       Date:  2003-04-11       Impact factor: 3.402

9.  Macrophages and inflammatory mediators in chemical toxicity: a battle of forces.

Authors:  Debra L Laskin
Journal:  Chem Res Toxicol       Date:  2009-08       Impact factor: 3.739

10.  A novel small-molecule enantiomeric analogue of traditional (-)-morphinans has specific TLR9 antagonist properties and reduces sterile inflammation-induced organ damage.

Authors:  Rafaz Hoque; Ahmad Farooq; Ahsan Malik; Bobby N Trawick; David W Berberich; Joseph P McClurg; Karen P Galen; Wajahat Mehal
Journal:  J Immunol       Date:  2013-03-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.